bonus
Frictionless Medicine: Revolutionizing Surgery: Dr. Nels Carroll on Robotics, Healthtech, and Patient-First Care
In this installment of the Frictionless Medicine mini-series, host Geeta Patel interviews Dr. Nels Carroll, a board-certified cardiothoracic surgeon at Los Robles Health System.
Dr. Carroll discusses his journey from educator to pioneer in robotic thoracic surgery, the role of marketing in engaging doctors, and how he uses technology, data, and collaboration to provide patient-first healthcare. He shares insights on bridging educational skills with medical practice, handling patient concerns regarding advanced surgical procedures, and his groundbreaking work in Southern California, including the first-ever robotic chest wall reconstruction and single anesthetic robotic lung cancer resection in Ventura County.
The episode provides a deep dive into the evolving landscape of robotic surgery and the future of med-tech and AI in the medical field.
00:00 Introduction to Frictionless Medicine
00:13 Meet Dr. Nels Carroll
01:31 Dr. Carroll's Journey into Medicine
02:43 The Role of Education in Medicine
04:11 Patient Concerns and Communication
06:22 Adoption of Advanced Surgical Techniques
07:33 Marketing and Communication in Medicine
10:25 Innovative Surgical Milestones
19:58 Future of Med Tech and AI
25:15 Conclusion and Final Thoughts
Frictionless Medicine is a production from /prompt, the leading earned first creative marketing and communications agency. Grounded in the present, yet attuned to the future.
Produced and distributed by Simpler Media Productions.
Transcript
>> Speaker A: Welcome to Frictionless Marketing, the podcast that dives
Speaker:deep into the stories of the most innovative brands and the people
Speaker:moving them forward.
Speaker:Our mini series, Frictionless Medicine explores the
Speaker:HCP perspective on today's trends throughout the
Speaker:industry. Today we're joined by Dr.
Speaker:Nels Carroll, a board certified cardiothoracic
Speaker:surgeon at uh, Los Robles Health System. Join host
Speaker:Geeta Patel as Dr. Carol shares insights on staying ahead
Speaker:of trends, the role of marketing and engaging
Speaker:doctors, and his journey from educator to a
Speaker:pioneer in robotic thoracic surgery. Discover how
Speaker:he leverages technology, data and collaboration to
Speaker:strive for seamless patient First Healthcare.
Speaker:>> Geeta Patel: Dr. Carol, thank you so much for joining us.
Speaker:We're excited to have you here, especially as someone
Speaker:who's at the forefront of tech and AI and
Speaker:medicine. So we'd love to kick things off by just
Speaker:having you share a little bit about yourself and your background and
Speaker:what you're doing right now.
Speaker:>> Dr. Nels Carroll: Yeah, thank you so much for having me here. I'm, um,
Speaker:excited to speak with you guys. I'm a
Speaker:cardiothoracic surgeon. I work for Los Robles
Speaker:Medical System in Thousand Oaks, California, right
Speaker:outside of la. Did my surgical training in
Speaker:Texas, worked in Washington for a few years
Speaker:before coming here to California. Uh,
Speaker:big part of my practice is robotic
Speaker:surgery, so certainly a big slant towards
Speaker:technology and pushing some boundaries and
Speaker:some barriers to what has been done towards
Speaker:what we can do. So really
Speaker:excited to be here.
Speaker:>> Geeta Patel: Amazing. What inspired you to get
Speaker:into medicine and specifically into
Speaker:the robotic and tech side of things?
Speaker:>> Dr. Nels Carroll: Well, I had kind of a circuitous route into
Speaker:medicine. Actually coming out of school, I was
Speaker:in Teach for America, which is, I
Speaker:think of it, kind of like a domestic Peace Corps.
Speaker:I was really enthralled with the mission
Speaker:of serving underserved
Speaker:people, kind of giving them some of the opportunities that I had
Speaker:had through that process
Speaker:of learning how to be an educator. I really
Speaker:became fascinated with the concept of
Speaker:pursuing education in a different arena and that
Speaker:being medicine. So that's where I kind of made the
Speaker:big jump into wanting to pursue medicine.
Speaker:And then really, it was just a process of trial
Speaker:and error. Real interest in science and a real interest
Speaker:in surgery and refining
Speaker:processes and through interactions with
Speaker:some particularly excellent
Speaker:teachers and surgeons, realized what we
Speaker:were capable of doing by harnessing some of these
Speaker:resources to improve our
Speaker:processes.
Speaker:>> Geeta Patel: That's amazing. How do you feel like Teach for
Speaker:America has shaped you as a
Speaker:physician in terms of just being able to explain some of the
Speaker:most complex medical issues, but also some of
Speaker:these complex tech procedures with your
Speaker:patients? How do you feel like that's kind of given you the skills you need
Speaker:to speak with them? Them?
Speaker:>> Dr. Nels Carroll: Oh, I think it's huge. Aside from the technical
Speaker:responsibilities of a surgeon and what you're actually doing at the time of
Speaker:surgery, at least
Speaker:50% of the job is
Speaker:educating and communicating with patients and with their
Speaker:families. There's really no more vulnerable
Speaker:or scary time than being a patient
Speaker:undergoing open heart surgery or undergoing
Speaker:surgery for cancer. So it's incumbent
Speaker:upon me, it's incumbent upon us as the
Speaker:medical community, to the way I communicate it. Pull
Speaker:up a chair to the table. Working as
Speaker:a consultant for them, the patient is the
Speaker:chairman of the board. There's a lot of different people that
Speaker:pull up a chair to the table. So it's my job to
Speaker:really explain myself, give
Speaker:background, give context, and make sure
Speaker:that they feel comfortable and confident with what we're
Speaker:doing moving forward so that they can
Speaker:really just focus on
Speaker:healing and not be worried about
Speaker:things that are out of their control or that they don't understand
Speaker:that we can help them understand that background in
Speaker:education has been pivotal in helping
Speaker:me do my job.
Speaker:>> Geeta Patel: What would you say are some of the
Speaker:biggest hesitations or concerns among
Speaker:patients when you are discussing some
Speaker:of the more advanced surgical procedures using
Speaker:AI and tech?
Speaker:>> Dr. Nels Carroll: Oh, yeah, there's a whole
Speaker:spectrum. You hear these catchphrases
Speaker:and patients will say, listen, I don't
Speaker:want a robot operating on me, right?
Speaker:I'm coming to you as a surgeon. I don't know this
Speaker:robot, right? So it's just about communicating
Speaker:that. I think for everyone,
Speaker:it's just intuitive. The fears of the
Speaker:unknown. What's really important is just
Speaker:explaining that these are tools
Speaker:that allow us to. Allow me to do my job
Speaker:better. For example, within the field
Speaker:of lung cancer resection, standard
Speaker:approach in literature 50, 60 years ago
Speaker:was a thoracotomy. A big incision between the
Speaker:ribs, spread the ribs apart, looking
Speaker:directly at the lung, operate on the lung.
Speaker:There was a total seat change when that transitioned
Speaker:to thoracoscopic surgery. So we put in a
Speaker:camera, make smaller incisions,
Speaker:much less painful for the patient, much less time
Speaker:in the hospital. But then there's really now this
Speaker:total paradigm shift where it's not just
Speaker:a camera, um, but when we say we're doing
Speaker:it robotically, that camera is actually
Speaker:two cameras adjacent to each other,
Speaker:creates a stereoscopic visual
Speaker:input. So it's three dimensional.
Speaker:The degrees of freedom, the range of
Speaker:motion of the instruments is
Speaker:infinitely better than what we can do with
Speaker:standard, we say vats or
Speaker:videoscopic thoracic surgery.
Speaker:So those things are fascinating. They're very
Speaker:interesting. But what matters to the
Speaker:patient is it hurts
Speaker:less, the surgery is more accurate,
Speaker:the surgery is safer, they
Speaker:recover more quickly. Those are the things that
Speaker:matter. So I think keeping
Speaker:things in context and making it relatable
Speaker:is hugely important.
Speaker:>> Geeta Patel: No, that's really interesting when you talk about these
Speaker:advancements and, uh, it seems like since you're on
Speaker:the forefront of a lot of this, thinking about
Speaker:the peers in this field, are they
Speaker:as open to adopting these new methods?
Speaker:Do you feel like there are certain groups of
Speaker:physicians that are a little bit more open than others? And how
Speaker:does literature and how things are being
Speaker:communicated to them, um, impacting their
Speaker:adoption of these practices?
Speaker:>> Dr. Nels Carroll: Well, I think that's a really good question.
Speaker:Within any practice, any
Speaker:profession, when you're trying
Speaker:to move things forward,
Speaker:at times there's resistance. It
Speaker:has to do not so much
Speaker:with focusing on that
Speaker:as it does with being true to the
Speaker:process. In that if you're
Speaker:offering a, uh, safer,
Speaker:more effective
Speaker:process, it speaks for
Speaker:itself. I think
Speaker:communicating and building
Speaker:within the medical community to
Speaker:bring people on board, to make them aware.
Speaker:Part of what I really appreciate about the opportunity
Speaker:to talk to you guys in the context of
Speaker:marketing, you know, from my perspective within
Speaker:medicine, nothing that I do has to do with
Speaker:sales. So marketing, for me
Speaker:isn't about sales, but it's about
Speaker:communicating, it's about sharing.
Speaker:Within our medical community,
Speaker:people are so
Speaker:overwhelmed with information, especially our
Speaker:primary care physicians. They're being
Speaker:inundated from all these different
Speaker:specialists. And I'm one of those specialists, you
Speaker:know, so when I meet a, uh, primary care physician, a
Speaker:family medicine doc, for the first time, I'm coming
Speaker:to the office and I'm saying, hey, I'm Dr. Carol. You know, I'm a
Speaker:cardiothoracic surgeon. Initially, they
Speaker:might just gloss over, like, okay, I just met with a
Speaker:urologist yesterday. I'm going to meet with a
Speaker:neurosurgeon tomorrow. There's
Speaker:a new, uh, radiation oncologist that's
Speaker:coming to my office this afternoon. Like, how do I
Speaker:put all this into context? It's an
Speaker:ongoing pursuit, but to share that
Speaker:information. You know, I had a pivotal
Speaker:lesson in that as a medical student.
Speaker:Worked with a really fantastic surgeon,
Speaker:T. Sloan guy, that's his name. Really
Speaker:phenomenal robotic cardiac
Speaker:surgeon. Taught me so much, has
Speaker:continues to be a mentor. But we actually
Speaker:published his experience
Speaker:with building or
Speaker:recruiting into what he was doing.
Speaker:Because as a robotic mitral valve surgeon,
Speaker:it's a real niche. Oftentimes
Speaker:he had to get the word out to patients
Speaker:to let them know, hey, here's an alternative. You know,
Speaker:rather than a sternotomy, we can do this minimally,
Speaker:invasively. We can offer you a really tremendous
Speaker:surgery. So
Speaker:that continues to be in my mind
Speaker:about the importance of not just going one
Speaker:foot in front of the other, but
Speaker:sharing what we're doing and working and
Speaker:building and growing. And just one other thought
Speaker:to go along with that. It's. I'm not under
Speaker:any illusions that as I
Speaker:step into a new medical community, I'm, um,
Speaker:bringing a whole wealth of knowledge and nobody gets
Speaker:it. You know, the guys who've been doing thoracic
Speaker:surgery for 20 years, 30
Speaker:years, 40 years, have seen so
Speaker:much and have so much
Speaker:tremendous information and wisdom
Speaker:that they can help me with.
Speaker:So I think it's about bringing a little bit different experience,
Speaker:bringing it to the table, working together,
Speaker:and then moving forward.
Speaker:>> Geeta Patel: I mean, that's really great insight. I heard you
Speaker:say sharing is really important, so I kind of want to
Speaker:take a second to also just share and,
Speaker:um, talk a little bit about your recent accomplishments. You
Speaker:recently completed the first ever robotic
Speaker:chest wall reconstruction in all of Southern
Speaker:California. I just want to make sure I get this right. And the first
Speaker:ever single anesthetic robotic lung cancer
Speaker:resection in Ventura County. Is that correct?
Speaker:Correct. Okay, first of all,
Speaker:let's take a moment to say that is
Speaker:incredible. Um, just to be first ever and to
Speaker:be on the cutting edge and to do this is wonderful.
Speaker:I heard you say it's important to communicate and share a lot
Speaker:of this. And a lot of times what we do from a marketing
Speaker:standpoint is figure out how we can empower our patients
Speaker:to also get educated on these topics so that
Speaker:they're coming to their surgeons, that they're coming to their physicians
Speaker:and discussing some of these options. I'd love to hear from
Speaker:you on how you're sharing some of those great
Speaker:milestones with potential patients and
Speaker:trying to market it outside, or communicate it,
Speaker:if you will, outside of the physician world.
Speaker:>> Dr. Nels Carroll: Well, that's. Thank you. Yeah, I mean, these are really
Speaker:exciting. Uh, I think as a clinician, you're just kind of
Speaker:confronted with the situation, and you
Speaker:think about, what's the best way I can do this? And
Speaker:then when you come up with a creative
Speaker:strategy and it works,
Speaker:that's really exciting. And then you want to build from
Speaker:that. Just to be totally frank,
Speaker:how do we share that is something that
Speaker:we're very much grappling with. You know, the chest
Speaker:wall reconstruction. So a Little bit of context
Speaker:had a gentleman riding a motorcycle
Speaker:collided with a deer, fractured 10
Speaker:ribs. So he had 10 rib fractures, multiple
Speaker:displaced rib fractures. The consequence of
Speaker:that is he was dependent on a lot of oxygen, a lot of pain
Speaker:medicine. He was able to get up and breathe deeply
Speaker:and walk around. So the traditional
Speaker:approach to reconstructing that is to make
Speaker:a big incision all the way along the
Speaker:back towards the side,
Speaker:and to actually divide a lot of muscles
Speaker:and screw titanium plates into the
Speaker:ribs. That works, but it's
Speaker:painful and you want to be better. So
Speaker:the next step is to do that thoracoscopically. We
Speaker:talked about vat surgery, and so what we did is we took
Speaker:it the next step and did it robotically. The
Speaker:biggest incision that we made on this Jose, 2
Speaker:inches. We plated from the
Speaker:inside. We also did a cryonerve
Speaker:ablation the morning after surgery.
Speaker:He's breathing room air, he's walking, he's taking
Speaker:Tylenol. For that patient,
Speaker:it's phenomenal. It's exciting because you
Speaker:see the potential to improve the process.
Speaker:We didn't divide any muscle. We spread the
Speaker:muscle fibers. We do these little finite
Speaker:things to really improve the process. But
Speaker:how do you share that? I don't really have an answer for
Speaker:that because it's just an area of growth, I guess, for
Speaker:me. And I shared that with
Speaker:our hospital. And they still
Speaker:are grappling with that a month later and
Speaker:haven't come up with anything to
Speaker:share that. Maybe because it seems a little
Speaker:esoteric or they're not familiar with it.
Speaker:The single anesthetic lung cancer
Speaker:is really a paradigm shift too.
Speaker:Just thinking patient first. So a
Speaker:patient might have a screening CT scan,
Speaker:a suspicious nodule. They're referred
Speaker:to a doctor, they're referred to another to get a
Speaker:biopsy, they're referred to another to get some
Speaker:testing done. They go get some other imaging
Speaker:done. They're referred to a surgeon
Speaker:in our community. On average, then it
Speaker:takes between 60 and 90 days
Speaker:from the time of initial suspicion to
Speaker:treatment. So with a single
Speaker:anesthetic event, what we're now doing,
Speaker:patient gets a suspicious CT scan.
Speaker:I'll see them within a week and get some
Speaker:other imaging done. We'll have a
Speaker:discussion within another week.
Speaker:We go to surgery, patient goes to
Speaker:sleep. I'll do a robotic navigational
Speaker:bronchoscopy and mediastinal staging.
Speaker:The pathologist is in the room with me, can
Speaker:tell me right away if it's cancer.
Speaker:If it's cancer while the patient's
Speaker:asleep. Proceed directly to complete
Speaker:Anatomic resection. So I'll take out the
Speaker:cancer, take out the lymph nodes, do
Speaker:nerve blocks, put in a drain.
Speaker:Two hours later, patient wakes up.
Speaker:90% of the time, they go home the following morning.
Speaker:When they go home the next day, we answer two
Speaker:questions. Was it cancer? Yes. What
Speaker:do we do about it? It's done. And
Speaker:especially with these early stage lung cancers,
Speaker:totally revolutionizes that experience
Speaker:for the patient. So rather than having three
Speaker:months of first
Speaker:wondering, then knowing
Speaker:that you have cancer, but not knowing the
Speaker:implication, and then
Speaker:worrying and waiting and worrying
Speaker:and going on WebMD and getting more
Speaker:worried, here, we're truncating that whole experience.
Speaker:So within two weeks, you find out what it is,
Speaker:you're treated, you go home and you take
Speaker:Tylenol for a week. And at the end of that
Speaker:experience, you can put in the rearview
Speaker:mirror. You know, that's what we talk about, that single
Speaker:anesthetic event. It's really
Speaker:exciting. But I think we're still grappling
Speaker:with how do you even take all that information
Speaker:and share it, uh, share that with
Speaker:our community doctors, share it with our patients.
Speaker:So even the hospital, still not
Speaker:really sure how they're going to share that. It's a work in
Speaker:progress.
Speaker:>> Geeta Patel: Well, just hearing both those patient
Speaker:experiences and stories immediately helped
Speaker:me truly understand the power of what
Speaker:you're doing. And, um, I'm blown away. It's
Speaker:really incredible. I do think that there's something
Speaker:within the patient testimonials and those patient stories,
Speaker:especially as someone who does focus groups
Speaker:with patients. Often you hear about the process.
Speaker:They worry about recovery, they worry about pain.
Speaker:Those are oftentimes the biggest concerns that they have
Speaker:is what's going to happen after. And it
Speaker:seems like that could be an interesting starting
Speaker:point. I do want to switch gears a
Speaker:little bit about just how you're learning about
Speaker:what's new and what's possible. How are
Speaker:you getting your information about, uh, the latest in
Speaker:medtech and AI when it comes to your
Speaker:field?
Speaker:>> Dr. Nels Carroll: Yeah, that's a great question. It's very much
Speaker:a, uh, ongoing changing dynamic. There's
Speaker:so many things happening in the field. For me
Speaker:personally, it's relying on
Speaker:mentors and friends and anecdotal information.
Speaker:There's a gentleman by the name of Yui Nguyen,
Speaker:who is a really fantastic thoracic
Speaker:surgeon, works in Portland, Oregon,
Speaker:taught me everything I know about robotic thoracic
Speaker:surgery. And he continues to be a source of
Speaker:information. But conferences,
Speaker:professional societies, for us in our world,
Speaker:the sts, the aats,
Speaker:those are very much where People
Speaker:are pushing those boundaries, but a lot of it has to do
Speaker:with a million things get published.
Speaker:Which things do you trust? You have to
Speaker:dig a little deeper to the person behind the article.
Speaker:That just comes from communication and
Speaker:relationships. I'm a young guy and I
Speaker:certainly am still very much learning how to
Speaker:navigate all of that and growing in that process.
Speaker:But I think having an ear to the ground
Speaker:on the thoracic side or the
Speaker:cancer world, we very
Speaker:much are multidisciplinary. We have a
Speaker:tumor board discussion. So every patient with lung
Speaker:cancer that needs to be discussed or worked through.
Speaker:I'm meeting with medical oncology, radiation
Speaker:oncology, pathology,
Speaker:radiology, diagnostic
Speaker:radiology. We have a tumor navigator. We have
Speaker:these meetings, and there's so much
Speaker:robust information coming from all these
Speaker:different disciplines. Again, it comes
Speaker:down to being open, to
Speaker:participating and to asking more
Speaker:questions so that I can be responsible
Speaker:as an advocate for the patient. Uh, especially
Speaker:because I'm, um, as all of us taking on a lot of
Speaker:responsibility. If I'm going to make an incision, I
Speaker:owe it to the patient to be entirely
Speaker:prepared for the consequences of those
Speaker:actions. Kind of a muddy answer to a
Speaker:fairly clear question, but I think it
Speaker:just has to do with keeping my eyes and ears open
Speaker:and communicating and admitting that there's
Speaker:a lot that I don't know so that I can
Speaker:find answers to those questions.
Speaker:>> Geeta Patel: It sounds like, um, we hear a lot about how
Speaker:valuable conferences are because it gives you all a
Speaker:moment to just stop and really focus on
Speaker:what's new, the new data, and to your point, who's
Speaker:publishing it and what that study looks like. We've heard that
Speaker:quite a bit. It sounds like for this field in particular,
Speaker:what's unique that we haven't heard as much
Speaker:is advocating for it and having other
Speaker:physicians advocating for it, for the future of the
Speaker:program and for the spread of that data.
Speaker:I think that's very interesting and unique to the
Speaker:MedTech and AI space. I'm
Speaker:curious to know what your thoughts are
Speaker:on the future. I say that with
Speaker:10 years from now, do you see this
Speaker:being the common practice, or
Speaker:do you still see that because there's so much advancement
Speaker:happening that it's still going to be a slower adoption?
Speaker:>> Dr. Nels Carroll: So great question. It's something that we all kind of wonder
Speaker:about. What's. Where are we going forward?
Speaker:My practice really is one foot in two
Speaker:worlds because there's a thoracic side of things.
Speaker:Lung cancer. Absolutely.
Speaker:Robotic thoracic surgery is
Speaker:more and more common. In training,
Speaker:trainees are coming out with that experience,
Speaker:they're sharing that and they're building from that, and
Speaker:it's growing. And the benefits are just
Speaker:irrefutable. In the cardiac side of things,
Speaker:too, there's going to be a tremendous amount of change.
Speaker:One of the things that we
Speaker:continue to wonder about is the
Speaker:transition from open cardiac surgery
Speaker:to these transcatheter processes.
Speaker:So as a patient, the concept of a
Speaker:transcatheter, meaning, for example,
Speaker:the aortic valve in the heart is
Speaker:very prone to aging because it's in the high
Speaker:pressure area of the heart. The
Speaker:aortic valve tends to calcify, becomes
Speaker:stenotic. And the natural history of that
Speaker:is that, uh, valve needs to be replaced or else
Speaker:the life expectancy declines
Speaker:precipitously.
Speaker:Historically, to replace that valve, we had
Speaker:to open the chest, arrest the heart,
Speaker:take that valve out, and sew in a new one. And
Speaker:that's still a really good surgery.
Speaker:But what
Speaker:we have developed as a medical community
Speaker:is the ability to replace that valve through
Speaker:a catheter. So much like, you know, I
Speaker:described to a patient, you know, you've seen a ship in a
Speaker:bottle and you look at that and you say, how the heck
Speaker:did they get that into that bottle, through that narrow little
Speaker:neck? Well, it was folded delicately
Speaker:in a way that allowed it to fit through there. We now have
Speaker:engineered these valves in a way that we
Speaker:can fold them down, put them into a very
Speaker:narrow catheter, introduce it to an artery
Speaker:in the hip, slide it up into position,
Speaker:release it, pushes the old valve out of the way and the
Speaker:new valve is functional in its place. We call that
Speaker:TAVR Transcatheter Aortic Valve
Speaker:Replacements. TAVR initially
Speaker:was just for really high risk
Speaker:folks who couldn't tolerate open
Speaker:surgery. And then we've seen where
Speaker:with more experience and more refinement of
Speaker:technique and technology,
Speaker:these valves work very well.
Speaker:So we've gone from offering them just to high risk
Speaker:patients to intermediate risk
Speaker:patients. And now we're looking at more and more
Speaker:applications, younger patients, healthier
Speaker:patients. The implications of
Speaker:that are really, uh, a burgeoning topic
Speaker:of discussion. For example,
Speaker:Medtronic is a company that makes a really terrific
Speaker:valve, and we've seen through recent
Speaker:the SMART trial data that
Speaker:particularly for a small annulus,
Speaker:which it's a narrow space and
Speaker:you're replacing it with this valve, the
Speaker:Medtronic valve works great. So
Speaker:we've got this excellent data that really
Speaker:is kind of pushing our thinking to
Speaker:when is the right time for surgery and when is the
Speaker:right time for a transcatheter option. We
Speaker:always want to offer the patient the least
Speaker:morbid, least painful procedure, but
Speaker:at the same time, we want to offer the most
Speaker:durable, most effective treatment.
Speaker:So it really takes a lot of
Speaker:longitudinal data and a lot of
Speaker:thoughtful collaboration to find the
Speaker:sweet spot for that. Where that will go
Speaker:in the future is really interesting,
Speaker:especially as we branch out into other
Speaker:valves. I have, uh, a tremendous
Speaker:good fortune of working with Dr. Cybul
Speaker:Carr, who's a
Speaker:absolute international expert in structural
Speaker:heart or transcatheter interventions for
Speaker:valvular disease. We're pushing the
Speaker:boundaries on some tricuspid valve
Speaker:interventions, mitral valve interventions,
Speaker:things that we once thought we could only do
Speaker:surgically. And I think
Speaker:seeing that progress
Speaker:and seeing the experience and courage of guys like
Speaker:Dr. Carr to help us try
Speaker:things and push forward really brings a
Speaker:lot of confidence that that
Speaker:area of medicine is only going to continue to grow.
Speaker:Certainly there's still always going to be a role for
Speaker:surgery. And the more thoughtful and collaborative we
Speaker:are, the more effectively we can
Speaker:utilize surgery and transcatheter
Speaker:interventions together. So, uh, lots
Speaker:to be discussed, lots to see, but
Speaker:really exciting.
Speaker:>> Geeta Patel: Yeah, it sounds like we're a lot closer in
Speaker:some fields than others than we think. So
Speaker:it is very exciting. Well, I just want to
Speaker:close by thanking you so much for your
Speaker:time and just sharing
Speaker:all these advancements with us. It's very exciting
Speaker:to see where we're headed in the medical
Speaker:world and how much innovation has
Speaker:happened over the last 10 to 15 years to get us
Speaker:to a place of less pain, less
Speaker:invasiveness. And I think your work has a
Speaker:lot and is contributing a lot to this and we're
Speaker:all very grateful for it. So thank you.
Speaker:>> Dr. Nels Carroll: Well, thank you. Thank you so much for having me. Honestly, I
Speaker:learned a lot from you guys and so
Speaker:I appreciate you giving me an opportunity to speak. I love
Speaker:to connect and learn more from other folks as we're all
Speaker:trying to do the same thing. We're trying to
Speaker:improve our patients lives. So thank you so much.
Speaker:>> Speaker A: Thank you for listening to this episode of the Frictionless Marketing
Speaker:podcast. For a complete transcript of
Speaker:this conversation or more information on Prompt,
Speaker:please Visit us at ahmeetprompt.co.
Speaker:if you found this episode insightful, share it with your connections
Speaker:on LinkedIn. To learn
Speaker:more about how to make marketing frictionless. Purchase Friction
Speaker:Fatigue by Prompt CEO Paul Dyer
Speaker:online and at booksellers worldwide.
Speaker:Frictionless Marketing is a production from Prompt, the leading
Speaker:earned first creative marketing and communications agency.
Speaker:Grounded in the present, yet attuned to the future.
Speaker:Produced and distributed by simpler media productions.
